GPT-Rosalind (OpenAI) vs ChatGPT
Which one should you pick? Here's the full breakdown.
GPT-Rosalind (OpenAI)
OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
ChatGPT
The chatbot that started the AI revolution -- most popular AI assistant in the world
| Category | GPT-Rosalind (OpenAI) | ChatGPT |
|---|---|---|
| Ease of Use | 3.0 | 10.0 |
| Output Quality | 9.0 | 8.0 |
| Value | 7.0 | 8.0 |
| Features | 8.0 | 9.0 |
| Overall | 6.8 | 8.8 |
Pricing Comparison
| Feature | GPT-Rosalind (OpenAI) | ChatGPT |
|---|---|---|
| Free Tier | No | Yes |
| Starting Price | Invite only | $0 |
Benchmark Head-to-Head
GPT-5.4 benchmarks — GPT-Rosalind (OpenAI) has no published benchmarks
| Benchmark | Description | Score |
|---|---|---|
| MMLU | Knowledge across 57 subjects | 91% |
| GPQA Diamond | Graduate-level science questions | 92.8% |
| AIME 2024 | Competition math problems | 83.3% |
| HumanEval | Python code generation | 95% |
| SWE-bench | Real GitHub issue fixing | 72% |
| ARC-AGI | Abstract reasoning puzzles | 73.3% |
Which Should You Pick?
Pick GPT-Rosalind (OpenAI) if...
- ✓Higher output quality (9 vs 8)
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Visit GPT-Rosalind (OpenAI)Pick ChatGPT if...
- ✓Easier to use (10 vs 3)
- ✓Better value for money (8/10)
- ✓More features (9 vs 8)
- ✓Has a free tier
Everyone. Seriously -- if you're new to AI or want the most complete all-in-one package, ChatGPT is the default recommendation.
Visit ChatGPTOur Verdict
ChatGPT is the clear winner here with 8.8/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but ChatGPT outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.